GILT REQUIRED FOR RTL550-CYS-MOG TO TREAT EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS

MHC class II-derived recombinant T cell receptor ligands (RTLs) modulate the behavior of pathogenic T cells and can reverse clinical and histological signs of autoimmune disease in experimental autoimmune encephalomyelitis (EAE), experimental autoimmune uveitis (EAU) and collagen-induced arthritis (...

Full description

Saved in:
Bibliographic Details
Main Authors: Burrows, Gregory G., Meza-Romero, Roberto, Huan, Jianya, Sinha, Sushmita, Mooney, Jeffrey L., Vandenbark, Arthur A., Offner, Halina
Format: Artigo
Language:Inglês
Published: 2012
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3348371/
https://ncbi.nlm.nih.gov/pubmed/22392628
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11011-012-9289-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items